Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VDR | P11473 | 3/20 | 0.74 |
| ▸ | USP2 | O75604 | 1/20 | 0.74 |
| ▸ | ST6GAL1 | P15907 | 1/20 | 0.69 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | CASP7 | P55210 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22894394 | 1.00 | VDR (0.74) | VDRUSP2ST6GAL1ABCC4TP53 | |
| SCHEMBL22894443 | 1.00 | VDR (0.74) | VDRUSP2ST6GAL1ABCC4TP53 | |
| SCHEMBL22894582 | 0.96 | VDR (0.67) | VDRUSP2ST6GAL1ABCC4TP53 | |
| SCHEMBL22894586 | 0.92 | VDR (0.67) | VDRUSP2ST6GAL1ABCC4GPBAR1 | |
| SCHEMBL22894575 | 0.89 | VDR (0.58) | VDRUSP2ST6GAL1ABCC4 | |
| SCHEMBL5063047 | 0.88 | VDR (0.84) | VDRUSP2ST6GAL1ABCC4TP53 | |
| SCHEMBL5063050 | 0.88 | VDR (0.84) | VDRUSP2ST6GAL1ABCC4TP53 | |
| SCHEMBL5063055 | 0.88 | VDR (0.84) | VDRUSP2ST6GAL1ABCC4TP53 | |
| SCHEMBL22854970 | 0.88 | VDR (0.84) | VDRUSP2ST6GAL1ABCC4TP53 | |
| SCHEMBL2860648 | 0.87 | VDR (0.82) | VDRUSP2ST6GAL1ABCC4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210009569-A1 | SYNTHETIC RECEPTORS FOR IONOPHORIC COMPOUNDS | UNIVERSITEIT GENT (BE) | 2021-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210009569-A1 | SYNTHETIC RECEPTORS FOR IONOPHORIC COMPOUNDS | TACR1, VIPR1, QRFPR | VDR 312/4885USP2 4594/4885ST6GAL1 2514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.